Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins

Antimicrob Agents Chemother. 1988 Aug;32(8):1243-6. doi: 10.1128/AAC.32.8.1243.

Abstract

A highly cephem-resistant Escherichia coli strain, FP1546, isolated from the fecal flora of laboratory dogs previously administered beta-lactam antibiotics was found to produce a beta-lactamase, FEC-1, of 48-kilodalton size and pI 8.2. FEC-1 hydrolyzed cefuroxime, cefotaxime, cefmenoxime, and ceftriaxone, as well as the enzymatically less-stable antibiotics cephaloridine, cefotiam, and cefpiramide. Of the oxyimino-cephalosporins, ceftizoxime was fairly stable to FEC-1. FEC-1 differed notably from chromosomal E. coli cephalosporinase, especially in its broad-spectrum substrate profile and its high inhibition by clavulanic acid, sulbactam, and imipenem. A conjugation study revealed that FEC-1 was encoded by a 74-megadalton plasmid, pFCX1. This may be the first instance of a plasmid-mediated oxyimino-cephalosporinase from E. coli.

MeSH terms

  • Animals
  • Cephalosporins / metabolism*
  • Cephalosporins / pharmacology
  • Conjugation, Genetic
  • DNA, Bacterial / analysis
  • Dogs
  • Drug Resistance, Microbial
  • Electrophoresis, Agar Gel
  • Escherichia coli / drug effects
  • Escherichia coli / enzymology*
  • Escherichia coli / genetics
  • Hydrolysis
  • Kinetics
  • R Factors*
  • Substrate Specificity
  • beta-Lactamase Inhibitors
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism*

Substances

  • Cephalosporins
  • DNA, Bacterial
  • beta-Lactamase Inhibitors
  • beta-Lactamases